Clinical Trial Update: Cobimetinib (Targeted Therapy) Plus Atezolizumab (Immunotherapy) in Participants With Advanced Melanoma Whose Cancer Has Worsened During or After Treatment With Previous Immunotherapy and Atezolizumab Monotherapy in Participants With Previously Untreated Advanced Melanoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating cobimetinib with atezolizumab in advanced melanoma, including patients whose disease progressed after prior immunotherapy and a cohort …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• Cobimetinib (cobimetinib)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Malignant Melanoma | Phase 1 | Status: COMPLETED | Results posted: 2020-06-12